LENSAR, Inc. (LNSR)
USD 14.06
(-0.28%)
USD 14.06
(-0.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 33.33 Million USD | -19.67% |
| 2022 | 40.13 Million USD | 7.06% |
| 2021 | 37.48 Million USD | 15.07% |
| 2020 | 32.57 Million USD | 25.57% |
| 2019 | 25.94 Million USD | 37.07% |
| 2018 | 18.92 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.24 Million USD | 5.14% |
| 2024 Q2 | 8.13 Million USD | -1.31% |
| 2023 Q2 | 9.62 Million USD | 10.91% |
| 2023 Q1 | 8.68 Million USD | -4.55% |
| 2023 FY | 32.23 Million USD | -19.67% |
| 2023 Q4 | 7.83 Million USD | 13.3% |
| 2023 Q3 | 6.91 Million USD | -28.16% |
| 2022 Q3 | 7.97 Million USD | -31.8% |
| 2022 Q2 | 11.69 Million USD | 2.77% |
| 2022 Q1 | 11.37 Million USD | 19.21% |
| 2022 FY | 40.13 Million USD | 7.06% |
| 2022 Q4 | 9.09 Million USD | 14.09% |
| 2021 Q2 | 8.83 Million USD | -2.87% |
| 2021 Q3 | 10.01 Million USD | 13.39% |
| 2021 Q4 | 9.54 Million USD | -4.73% |
| 2021 FY | 37.48 Million USD | 15.07% |
| 2021 Q1 | 9.09 Million USD | -21.01% |
| 2020 FY | 32.57 Million USD | 25.57% |
| 2020 Q1 | 6.66 Million USD | 1.08% |
| 2020 Q4 | 11.51 Million USD | 33.75% |
| 2020 Q3 | 8.6 Million USD | 48.7% |
| 2020 Q2 | 5.78 Million USD | -13.17% |
| 2019 Q1 | 5.36 Million USD | 0.0% |
| 2019 Q2 | 5.36 Million USD | 0.0% |
| 2019 Q3 | 8.61 Million USD | 60.48% |
| 2019 Q4 | 6.59 Million USD | -23.41% |
| 2019 FY | 25.94 Million USD | 37.07% |
| 2018 FY | 18.92 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -197.006% |
| Cerus Corporation | 143.15 Million USD | 76.713% |
| OrthoPediatrics Corp. | 137.01 Million USD | 75.671% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -193.428% |
| Talis Biomedical Corporation | 67.18 Million USD | 50.383% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -33.633% |
| Inogen, Inc. | 236.08 Million USD | 85.88% |
| Spectral AI, Inc. | 20.86 Million USD | -59.778% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 40.468% |
| CVRx, Inc. | 76.14 Million USD | 56.219% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -844.899% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -166.923% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.005% |
| Venus Concept Inc. | 80.47 Million USD | 58.576% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 41.08% |
| Bioventus Inc. | 409.91 Million USD | 91.868% |
| BrainsWay Ltd. | 28.01 Million USD | -18.981% |
| Envoy Medical, Inc. | 17.89 Million USD | -86.255% |
| electroCore, Inc. | 32.03 Million USD | -4.074% |
| IceCure Medical Ltd | 16.87 Million USD | -97.535% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 21.437% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -89.054% |
| MaxCyte, Inc. | 84.84 Million USD | 60.71% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -168.584% |
| Nexalin Technology, Inc. | 5.78 Million USD | -476.612% |
| PAVmed Inc | 64.82 Million USD | 48.577% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 34.735% |
| RxSight, Inc. | 103.85 Million USD | 67.9% |
| Sight Sciences, Inc. | 126.44 Million USD | 73.637% |
| SI-BONE, Inc. | 156.35 Million USD | 78.679% |
| TELA Bio, Inc. | 84.18 Million USD | 60.402% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 52.415% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 83.608% |
| LivaNova PLC | 843.54 Million USD | 96.048% |
| 908 Devices Inc. | 68.08 Million USD | 51.034% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 93.107% |
| Nemaura Medical Inc. | 7.13 Million USD | -366.969% |
| NeuroPace, Inc. | 75.29 Million USD | 55.727% |
| Apyx Medical Corporation | 51.01 Million USD | 34.658% |
| Cutera, Inc. | 197.72 Million USD | 83.14% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -34.522% |
| BioSig Technologies, Inc. | 28.53 Million USD | -16.845% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 82.59% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 7.554% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.014% |
| Axonics, Inc. | 270.2 Million USD | 87.663% |
| Outset Medical, Inc. | 198.77 Million USD | 83.229% |
| IRIDEX Corporation | 31.81 Million USD | -4.784% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 81.503% |
| IRadimed Corporation | 30.12 Million USD | -10.667% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -290.717% |
| INVO Bioscience, Inc. | 7.85 Million USD | -324.484% |
| Telesis Bio, Inc. | 63.48 Million USD | 47.493% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 66.14% |
| Varex Imaging Corporation | 224.8 Million USD | 85.171% |
| Quipt Home Medical Corp. | 148.66 Million USD | 77.577% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -184.364% |
| Pulmonx Corporation | 112.68 Million USD | 70.417% |
| Dynatronics Corporation | 9.9 Million USD | -236.455% |
| Modular Medical, Inc. | 17.52 Million USD | -90.176% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -65.136% |
| Semler Scientific, Inc. | 38.94 Million USD | 14.4% |
| InMode Ltd. | 215.68 Million USD | 84.544% |
| Bruker Corporation | 1.07 Billion USD | 96.903% |
| Cytosorbents Corporation | 48.33 Million USD | 31.034% |
| DexCom, Inc. | 1.69 Billion USD | 98.029% |
| Align Technology, Inc. | 2.07 Billion USD | 98.395% |
| Viveve Medical, Inc. | 22.17 Million USD | -50.345% |
| ZimVie Inc. | 275.12 Million USD | 87.883% |
| Movano Inc. | 29.69 Million USD | -12.28% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 75.715% |
| Nexalin Technology, Inc. | 5.78 Million USD | -476.612% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -844.899% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 94.453% |
| Profound Medical Corp. | 33.6 Million USD | 0.795% |
| Insulet Corporation | 939.9 Million USD | 96.453% |
| enVVeno Medical Corporation | 25.23 Million USD | -32.087% |
| Surmodics, Inc. | 98.69 Million USD | 66.224% |
| iCAD, Inc. | 22.22 Million USD | -49.993% |
| Nuwellis, Inc. | 22.61 Million USD | -47.42% |
| Biotricity, Inc. | 17.18 Million USD | -93.988% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 92.524% |
| Aethlon Medical, Inc. | 12.27 Million USD | -171.521% |
| InspireMD, Inc. | 22.95 Million USD | -45.255% |
| PAVmed Inc. | 64.82 Million USD | 48.577% |
| BIOLASE, Inc. | 34.66 Million USD | 3.823% |
| Beyond Air, Inc. | 61.7 Million USD | 45.971% |
| FONAR Corporation | 28.6 Million USD | -16.54% |
| AxoGen, Inc. | 149.33 Million USD | 77.677% |
| Vivani Medical, Inc. | 26.96 Million USD | -23.627% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 81.176% |
| Inari Medical, Inc. | 448.59 Million USD | 92.569% |
| UFP Technologies, Inc. | 58.08 Million USD | 42.612% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -576.516% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -427.611% |
| Tenon Medical, Inc. | 16.96 Million USD | -96.464% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -350.913% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 24.413% |
| AdaptHealth Corp. | 1.07 Billion USD | 96.908% |
| Sintx Technologies, Inc. | 15.2 Million USD | -119.301% |
| NanoVibronix, Inc. | 4.97 Million USD | -570.34% |
| Quanterix Corporation | 118.1 Million USD | 71.773% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -184.364% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -130.827% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 91.51% |
| TransMedics Group, Inc. | 182.82 Million USD | 81.766% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -18.781% |
| NeuroMetrix, Inc. | 11.09 Million USD | -200.353% |
| Hyperfine, Inc. | 52.87 Million USD | 36.95% |
| Establishment Labs Holdings Inc. | 172 Million USD | 80.619% |
| Biomerica, Inc. | 6.97 Million USD | -377.73% |
| Bone Biologics Corporation | 9.42 Million USD | -253.574% |
| AVITA Medical, Inc. | 80.77 Million USD | 58.732% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -223.298% |
| Silk Road Medical, Inc | 186.35 Million USD | 82.112% |